Pacira Biosciences Inc banner

Pacira Biosciences Inc
F:82P

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
F:82P
Watchlist
Price: 19.9 EUR 2.05% Market Closed
Market Cap: €926.3m

Profitability Summary

Pacira Biosciences Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Pacira Biosciences Inc

Margins Comparison
Pacira Biosciences Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Pacira Biosciences Inc
NASDAQ:PCRX
958.4m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
847.5B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
576.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
294.3B USD
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
218.1B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.3B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
156.8B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
119.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Pacira Biosciences Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Pacira Biosciences Inc
NASDAQ:PCRX
958.4m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
847.5B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
576.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
294.3B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
218.1B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
229.3B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
156.8B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
119.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Pacira Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett